Company Filing History:
Years Active: 2009-2013
Title: Innovations by Gavin J Gordon
Introduction
Gavin J Gordon is an accomplished inventor based in West Newbury, MA (US). He holds three patents that focus on advancements in diagnostic methods related to cancer. His work has significant implications for the medical field, particularly in the diagnosis and treatment of malignant conditions.
Latest Patents
Gordon's latest patents include innovative methods for diagnosing biological states or conditions based on gene expression data. One of his notable inventions provides diagnostic and prognostic tests that utilize ratios of gene expression from tissue samples, specifically cancer tissue samples. This invention identifies sets of genes that are differentially expressed in malignant pleural mesothelioma, enabling the discrimination between normal and malignant tissues. It also aids in classifying tumors, predicting outcomes, and monitoring treatment regimens.
Another significant patent focuses on diagnostic tests using gene expression ratios from cell or tissue samples, including cancer cells. This invention identifies sets of genes expressed differently in normal and cancer lung cells, facilitating the differentiation between normal and malignant cells. Similar to his previous work, this patent also supports tumor classification, outcome prediction, and treatment monitoring.
Career Highlights
Gordon has made substantial contributions to the field of medical diagnostics through his innovative inventions. His work has been recognized in various research institutions, enhancing the understanding of cancer biology and improving patient outcomes.
Collaborations
Gordon has collaborated with notable professionals in his field, including Raphael Bueno and Roderick V Jensen. These collaborations have further enriched his research and development efforts.
Conclusion
Gavin J Gordon's contributions to cancer diagnostics through his patents demonstrate his commitment to advancing medical science. His innovative approaches have the potential to significantly impact the diagnosis and treatment of cancer, ultimately benefiting patients and healthcare providers alike.